Join Now | Sign in

Drug Notebook

Save

Generic Name: methotrexate

View All Brands

An antirheumatic - treats Trophoblastic Disease, Psoriasis, Lymphoma, Mycosis Fungoides, Acute Lymph... more

FDA Alerts

Experience of Supervising Clinician

Administer only under supervision of qualified clinicians experienced in use of antimetabolite therapy.

Serious Toxic Reactions (Sometimes Fatal) Possible

Deaths reported with use in treatment of malignancy, psoriasis, and rheumatoid arthritis.
Use only for treatment of life-threatening neoplastic diseases or severe, recalcitrant, disabling psoriasis or rheumatoid arthritis in patients who have not responded adequately to other forms of therapy.
Closely monitor patients for bone marrow, hepatic, pulmonary, or renal toxicities. (See Major Toxicities under Cautions.)
Inform patients of risks involved with therapy and importance of remaining under care of clinician throughout therapy.

High-Dose Regimens

Use of high-dose regimens recommended for treatment of osteosarcoma requires meticulous care. (See High-Dose Methotrexate Therapy with Leucovorin Rescue and also Osteosarcoma, under Dosage and Administration.)
Use of high-dose regimens for other neoplastic diseases is investigational; therapeutic advantage not established.

Formulations or Diluents Containing Preservatives

Do not use formulations or diluents containing preservatives for intrathecal administration or high-dose therapy.

Fetal/Neonatal Morbidity and Mortality

Fetal death and/or congenital anomalies reported. Not recommended for use in women of childbearing potential unless potential benefit clearly outweighs risks; do not use in pregnant women with psoriasis or rheumatoid arthritis. (See Contraindications and also Fetal/Neonatal Morbidity and Mortality, under Cautions.)

Reduced Elimination

Elimination reduced in patients with renal impairment, ascites, or pleural effusions. Carefully monitor for toxicity in such patients; dosage reduction or discontinuance may be required.

Concomitant Therapy with NSAIAs

Unexpectedly severe, sometimes fatal, myelosuppression, aplastic anemia, and GI toxicity reported with concomitant use of methotrexate (usually at high dosages) and some NSAIAs. (See Specific Drugs under Interactions.)

Hepatotoxicity

Possible hepatotoxicity, fibrosis, and cirrhosis, generally only after prolonged use. (See Hepatic Effects under Cautions.)
Acute liver enzyme elevations frequently observed; usually transient and asymptomatic and do not appear predictive of subsequent hepatic disease.
Liver biopsy after sustained use often shows histologic changes. Fibrosis and cirrhosis may not be preceded by symptoms or abnormal liver function tests in patients with psoriasis; periodic liver biopsies usually recommended in such patients undergoing long-term therapy.
Persistent abnormalities in liver function tests may precede appearance of fibrosis or cirrhosis in patients with rheumatoid arthritis.

Pulmonary Toxicity

Potentially dangerous pulmonary lesions, not always reversible, may occur acutely at any time during therapy and have been reported at dosages as low as 7.5 mg weekly. Pulmonary symptoms (especially dry, nonproductive cough) may require therapy interruption and careful evaluation.

GI Toxicity

Diarrhea and ulcerative stomatitis require interruption of therapy; otherwise, hemorrhagic enteritis and death from intestinal perforation may occur.

Malignant Lymphomas

Malignant lymphomas (e.g., non-Hodgkin’s lymphoma) may occur in patients receiving low-dose oral therapy; such lymphomas may regress following methotrexate discontinuance and may not require cytotoxic therapy. If the lymphoma does not regress following discontinuance, institute appropriate therapy.

Tumor Lysis Syndrome

May induce tumor lysis syndrome in patients with rapidly growing tumors; appropriate pharmacologic and supportive treatment may prevent or alleviate syndrome.

Dermatologic Reactions

Severe, occasionally fatal skin reactions reported following single or multiple doses; reactions occurred within days of oral, IM, IV, or intrathecal administration. Recovery reported with discontinuance of therapy. (See Dermatologic and Sensitivity Reactions under Cautions.)

Opportunistic Infections

Potentially fatal opportunistic infections, especially Pneumocystis jiroveci (formerly Pneumocystis carinii) pneumonia.

Concomitant Radiotherapy

Possible increased risk of soft tissue necrosis and osteonecrosis in patients receiving methotrexate concomitantly with radiotherapy.

Drug Info Tools

Pill Finder

Search by color, shape and markings. click here

Drug Interaction Checker

Check any 2 drugs for interactions. click here

Drug Compare

Compare any two drugs side by side. click here

Healthline Part D Plan Selector

Medicare's drug plans are subsidized by the US federal government and offered through insurers.

Marketplace

Licensed from

methotrexate

Page: 1 2 3 Next >

(meth oh TREX ate)

What is the most important information I should know about methotrexate injection?

Methotrexate injection can cause serious or life-threatening side effects on your liver, lungs, kidneys, and bone marrow (immune system). To check for harmful effects, your blood will need to be tested on a regular basis. Your kidney or liver function may also need to be tested, and you may need an occasional liver biopsy or chest x-ray. Do not miss any scheduled appointments. You may not be able to receive methotrexate injection if you have liver disease (especially if caused by alcoholism), a blood cell or bone marrow disorder, or if you are breast-feeding a baby. Your doctor will decide if this treatment is right for you. Methotrexate can cause birth defects in an unborn baby. You should not use methotrexate to treat psoriasis or rheumatoid arthritis if you are pregnant. Use an effective form of birth control, whether you are a man or a woman. Tell your doctor if you or your sexual partner become pregnant during treatment.

There are many other medicines that can interact with methotrexate injection. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor. Keep a list with you of all the medicines you use and show this list to any doctor or other healthcare provider who treats you.

What is methotrexate injection?

Methotrexate injection interferes with the growth of certain cells of the body, especially cells that reproduce quickly, such as cancer cells, bone marrow cells, and skin cells.

Methotrexate injection is used to treat leukemia and certain types of cancer of the breast, skin, head and neck, or lung. Methotrexate injection is also used to treat severe psoriasis and rheumatoid arthritis.

Methotrexate injection is usually given after other medications have been tried without successful treatment of symptoms.

Methotrexate injection may also be used for other purposes not listed in this medication guide.

What should I discuss with my healthcare provider before receiving methotrexate injection?

You should not use this medication if you are allergic to methotrexate. Do not use methotrexate injection to treat psoriasis or rheumatoid arthritis if you have:

liver disease;
alcoholism or cirrhosis of the liver;
a blood cell disorder such as anemia (lack of red blood cells) or leukopenia (lack of white blood cells);
a weak immune system or bone marrow disorder; or
if you are breast-feeding a baby.

Methotrexate injection is sometimes used to treat cancer even when patients do have one of the conditions listed above. Your doctor will decide if this treatment is right for you.

Before receiving methotrexate injection, tell your doctor if you are allergic to any drugs, or if you have:

kidney or liver disease;
lung disease or pneumonia;
stomach ulcers, ulcerative colitis;
any type of infection; or
if you are receiving radiation treatments.

FDA pregnancy category X. Methotrexate injection can cause birth defects in an unborn baby. Do not use methotrexate injection to treat psoriasis or rheumatoid arthritis if you are pregnant. Tell your doctor right away if you become pregnant during treatment.

Use birth control to prevent pregnancy while you are receiving methotrexate injection, whether you are a man or a woman. Methotrexate injection use by either parent may cause birth defects.

If you are a man, use a condom to keep from causing a pregnancy while you are receiving methotrexate injection. Continue using condoms for at least 90 days after your treatment ends. If you are a woman, use an effective form of birth control while you are receiving methotrexate injection, and for at least one cycle of ovulation after your treatment ends.

Page: 1 2 3 Next >